Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
NDC API
0
VMF
0
API
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Roxatidine Acetate Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Roxatidine Acetate Hydrochloride, including repackagers and relabelers. The FDA regulates Roxatidine Acetate Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Roxatidine Acetate Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Roxatidine Acetate Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Roxatidine Acetate Hydrochloride supplier is an individual or a company that provides Roxatidine Acetate Hydrochloride active pharmaceutical ingredient (API) or Roxatidine Acetate Hydrochloride finished formulations upon request. The Roxatidine Acetate Hydrochloride suppliers may include Roxatidine Acetate Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Roxatidine Acetate Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Roxatidine Acetate Hydrochloride Drug Master File in Japan (Roxatidine Acetate Hydrochloride JDMF) empowers Roxatidine Acetate Hydrochloride API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Roxatidine Acetate Hydrochloride JDMF during the approval evaluation for pharmaceutical products. At the time of Roxatidine Acetate Hydrochloride JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Roxatidine Acetate Hydrochloride suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Roxatidine Acetate Hydrochloride Drug Master File in Korea (Roxatidine Acetate Hydrochloride KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Roxatidine Acetate Hydrochloride. The MFDS reviews the Roxatidine Acetate Hydrochloride KDMF as part of the drug registration process and uses the information provided in the Roxatidine Acetate Hydrochloride KDMF to evaluate the safety and efficacy of the drug.
After submitting a Roxatidine Acetate Hydrochloride KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Roxatidine Acetate Hydrochloride API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Roxatidine Acetate Hydrochloride suppliers with KDMF on PharmaCompass.
Roxatidine Acetate Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Roxatidine Acetate Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Roxatidine Acetate Hydrochloride GMP manufacturer or Roxatidine Acetate Hydrochloride GMP API supplier for your needs.
A Roxatidine Acetate Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Roxatidine Acetate Hydrochloride's compliance with Roxatidine Acetate Hydrochloride specifications and serves as a tool for batch-level quality control.
Roxatidine Acetate Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Roxatidine Acetate Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Roxatidine Acetate Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Roxatidine Acetate Hydrochloride EP), Roxatidine Acetate Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Roxatidine Acetate Hydrochloride USP).
LOOKING FOR A SUPPLIER?
